Vitamin D status in relation to inflammatory risk and albuminuria associated with polycyclic aromatic hydrocarbon exposure in the US population

References

• ATSDR. Agency for Toxic Substances and Disease Registry Toxicological Profile for Polycyclic Aromatic Hydrocarbons; 1995. http://www.atsdr.cdc.gov/toxprofiles/tp69.pdf. Accessed October 7, 2016.
   Google Scholar
• Alshaarawy O, Elbaz HA, Andrew ME. The association of urinary polycyclic aromatic hydrocarbon biomarkers and cardiovascular disease in the US population. Environ Int. 2016;89-90:174–178. doi:10.1016/j.envint.2016.02.006.
   PubMed Web of Science ®Google Scholar
• Alshaarawy O, Zhu M, Ducatman AM, Conway B, Andrew ME. Urinary polycyclic aromatic hydrocarbon biomarkers and diabetes mellitus. Occup Environ Med. 2014;71(6):437–441. doi:10.1136/oemed-2013-101987.
   PubMed Web of Science ®Google Scholar
• Farzan SF, Chen Y, Trachtman H, Trasande L. Urinary polycyclic aromatic hydrocarbons and measures of oxidative stress, inflammation and renal function in adolescents: NHANES 2003-2008. Environ Res. 2016;144:149–157. doi:10.1016/j.envres.2015.11.012.
   PubMed Web of Science ®Google Scholar
• Karimi P, Peters KO, Bidad K, Strickland PT. Polycyclic aromatic hydrocarbons and childhood asthma. Eur J Epidemiol. 2015;30(2):91–101. doi:10.1007/s10654-015-9988-6.
   PubMed Web of Science ®Google Scholar
• Shiue I. Are urinary polyaromatic hydrocarbons associated with adult hypertension, heart attack, and cancer? USA NHANES, 2011-2012. Environ Sci Pollut Res Int. 2015;22(21):16962–16968. doi:10.1007/s11356-015-4922-8.
   PubMed Web of Science ®Google Scholar
• Curfs DMJ, Knaapen AM, Pachen DMFA, et al. Polycyclic aromatic hydrocarbons induce an inflammatory atherosclerotic plaque phenotype irrespective of their DNA binding properties. Faseb J. 2005;19(10):1290–1292. doi:10.1096/fj.04-2269fje.
   PubMedGoogle Scholar
• Mallah MA, Changxing L, Mallah MA, et al. Polycyclic aromatic hydrocarbon and its effects on human health: An overeview. Chemosphere. 2022;296:133948. doi:10.1016/j.chemosphere.2022.133948.
   PubMed Web of Science ®Google Scholar
• Matsunawa M, Amano Y, Endo K, et al. The aryl hydrocarbon receptor activator benzo[a]pyrene enhances vitamin D3 catabolism in macrophages. Toxicol Sci. 2009;109(1):50–58. doi:10.1093/toxsci/kfp044.
   PubMed Web of Science ®Google Scholar
• Vogel CFA, Van Winkle LS, Esser C, Haarmann-Stemmann T. The aryl hydrocarbon receptor as a target of environmental stressors - Implications for pollution mediated stress and inflammatory responses. Redox Biol. 2020;34:101530. doi:10.1016/j.redox.2020.101530.
   PubMed Web of Science ®Google Scholar
• Mozos I, Marginean O. Links between Vitamin D deficiency and cardiovascular diseases. Biomed Res Int. 2015;2015:109275. doi:10.1155/2015/109275.
   PubMed Web of Science ®Google Scholar
• Xin L, Che B, Zhai B, et al. 1,25-Dihydroxy Vitamin D3 attenuates the oxidative stress-mediated inflammation induced by PM2.5via the p38/NF-kappaB/NLRP3 pathway. Inflammation. 2019;42(2):702–713. doi:10.1007/s10753-018-0928-y.
   PubMed Web of Science ®Google Scholar
• Kendrick J, Targher G, Smits G, Chonchol M. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis. 2009;205(1):255–260. doi:10.1016/j.atherosclerosis.2008.10.033.
   PubMed Web of Science ®Google Scholar
• Gentile G, Remuzzi G. Novel biomarkers for renal diseases? none for the moment (but one). J Biomol Screen. 2016;21(7):655–670. doi:10.1177/1087057116629916.
   PubMedGoogle Scholar
• Mehrotra R, Kermah DA, Salusky IB, et al. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int. 2009;76(9):977–983. doi:10.1038/ki.2009.288.
   PubMed Web of Science ®Google Scholar
• Zhao G, Ford ES, Li C, Croft JB. Serum 25-hydroxyvitamin D levels and all-cause and cardiovascular disease mortality among US adults with hypertension: the NHANES linked mortality study. J Hypertension. 2012;30(2):284–289. doi:10.1097/HJH.0b013e32834e1f0a.
   PubMed Web of Science ®Google Scholar
• Olden K, Lin YS, Gruber D, Sonawane B. Epigenome: biosensor of cumulative exposure to chemical and nonchemical stressors related to environmental justice. Am J Public Health. 2014;104(10):1816–1821. doi:10.2105/AJPH.2014.302130.
   PubMed Web of Science ®Google Scholar
• Hennig B, Ormsbee L, McClain CJ, et al. Nutrition can modulate the toxicity of environmental pollutants: implications in risk assessment and human health. Environ Health Perspect. 2012;120(6):771–774. doi:10.1289/ehp.1104712.
   PubMed Web of Science ®Google Scholar
• CDC. National Center for Health Statistics. National Health and Nutrition Examination Survey. Analytical Note for 25-Hydroxyvitamin D Data Analysis Using NHANES III (1988-1994), NHANES 2001-2006, and NHANES 2007-2010. Hyattsville, MD. Centers for Disease Control and Prevention; 2015. https://wwwn.cdc.gov/nchs/nhanes/vitamind/analyticalnote.aspx?b=2011&e=2012&d=VID_G. Accessed May 16, 2022.
   Google Scholar
• CDC. National Center for Health Statistics. National Health and Nutrition Examination Survey. Merge Feasibility File and NHANES Data. Hyattsville, MD. Centers for Disease Control and Prevention; 2012. https://www.cdc.gov/nchs/tutorials/nhanes-cms/Determine/Merge/index.htm. Accessed May 16, 2022.
   Google Scholar
• von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, STROBE Initiative The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–1499. doi:10.1016/j.ijsu.2014.07.013.
   PubMed Web of Science ®Google Scholar
• CDC. National Center for Health Statistics. National Health and Nutrition Examination Survey 1999–2010 Questionnaires, Datasets, and Related Documentation, 2012. Hyattsville, MD. Centers for Disease Control and Prevention; 2017. http://www.cdc.gov/nchs/nhanes.htm. Accessed March 1, 2017.
   Google Scholar
• Bruyere O, Cavalier E, Souberbielle JC, et al. Effects of vitamin D in the elderly population: current status and perspectives. Arch Public Health. 2014;72(1):32. doi:10.1186/2049-3258-72-32.
   PubMedGoogle Scholar
• Schleicher RL, Sternberg MR, Lacher DA, et al. A Method-bridging Study for Serum 25-hydroxyvitamin D to Standardize Historical Radioimmunoassay Data to Liquid Chromatography-Tandem Mass Spectrometry. Natl Health Stat Report. 2016;93:1–16. PMID:27139932
   PubMedGoogle Scholar
• Pearson TA, Mensah GA, Alexander RW, Centers for Disease C, Prevention and American Heart A, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499–511. doi:10.1161/01.cir.0000052939.59093.45.
   PubMed Web of Science ®Google Scholar
• Mancia G, Grassi G, European Society of Cardiology Joint National Committee VII and European Society of Hypertension/European Society of Cardiology guidelines for evaluating and treating hypertension: a two-way road? J Am Soc Nephrol. 2005;16 Suppl 1:S74–S77. doi:10.1681/asn.2004110963.
   PubMed Web of Science ®Google Scholar
• Amrein K, Scherkl M, Hoffmann M, et al. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr. 2020;74(11):1498–1513. doi:10.1038/s41430-020-0558-y.
   PubMed Web of Science ®Google Scholar
• Johnson CL, Paulose-Ram R, Ogden CL, et al. National Health and Nutrition Examination Survey. Analytic Guidelines, 1999-2010. National Center for Health Statistics. Vital Health Stat 2. 2013;161:1–24.
   Google Scholar
• Krishnan AV, Feldman D. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol. 2011;51:311–336. doi:10.1146/annurev-pharmtox-010510-100611.
   PubMed Web of Science ®Google Scholar
• Yin K, Agrawal DK. Vitamin D and inflammatory diseases. J Inflamm Res. 2014;7:69–87. doi:10.2147/JIR.S63898.
   PubMedGoogle Scholar
• Festa A, D'Agostino R, Howard G, Mykkänen L, Tracy RP, Haffner SM. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The insulin resistance atherosclerosis Study. Kidney Int. 2000;58(4):1703–1710. doi:10.1046/j.1523-1755.2000.00331.x.
   PubMed Web of Science ®Google Scholar
• Duni A, Liakopoulos V, Roumeliotis S, Peschos D, Dounousi E. Oxidative stress in the pathogenesis and evolution of chronic kidney disease: Untangling Ariadne's thread. IJMS. 2019;20(15):3711. doi:10.3390/ijms20153711.
   Google Scholar
• Ashraf AP, Fisher G, Alvarez J, et al. Associations of C-reactive protein to indices of vascular health and the influence of serum 25(OH)D status in healthy adults. J Nutr Metab. 2012;2012:475975. doi:10.1155/2012/475975.
   PubMedGoogle Scholar
• Hunter P. The inflammation theory of disease. The growing realization that chronic inflammation is crucial in many diseases opens new avenues for treatment. EMBO Rep. 2012;13(11):968–970. doi:10.1038/embor.2012.142.
   PubMed Web of Science ®Google Scholar
• Jeng HA, Pan CH, Diawara N, et al. Polycyclic aromatic hydrocarbon-induced oxidative stress and lipid peroxidation in relation to immunological alteration. Occup Environ Med. 2011;68(9):653–658. doi:10.1136/oem.2010.055020.
   PubMed Web of Science ®Google Scholar
• Han YY, Rosser F, Forno E, Celedon JC. Exposure to polycyclic aromatic hydrocarbons, vitamin D, and lung function in children with asthma. Pediatr Pulmonol. 2018;53(10):1362–1368. doi:10.1002/ppul.24084.
   PubMed Web of Science ®Google Scholar
• Kutuzova GD, DeLuca HF. 1,25-Dihydroxyvitamin D3 regulates genes responsible for detoxification in intestine. Toxicol Appl Pharmacol. 2007;218(1):37–44. doi:10.1016/j.taap.2006.10.005.
   PubMed Web of Science ®Google Scholar
• Shimada T. Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet. 2006;21(4):257–276. doi:10.2133/dmpk.21.257.
   PubMed Web of Science ®Google Scholar
• Tessum CW, Apte JS, Goodkind AL, et al. Inequity in consumption of goods and services adds to racial–ethnic disparities in air pollution exposure. Proc Natl Acad Sci U S A. 2019;116(13):6001–6006. doi:10.1073/pnas.1818859116.
   PubMed Web of Science ®Google Scholar
• Patel AP, Mehta SS, White AJ, et al. Urinary polycyclic aromatic hydrocarbon metabolites and mortality in the United States: A prospective analysis. PLoS One. 2021;16(6):e0252719-e0252719. doi:10.1371/journal.pone.0252719.
   Web of Science ®Google Scholar
• Harris SS. Vitamin D and African Americans. J Nutr. 2006;136(4):1126–1129. doi:10.1093/jn/136.4.1126.
   PubMed Web of Science ®Google Scholar
• Li Z, Romanoff LC, Lewin MD, et al. Variability of urinary concentrations of polycyclic aromatic hydrocarbon metabolite in general population and comparison of spot, first-morning, and 24-h void sampling. J Expo Sci Environ Epidemiol. 2010;20(6):526–535. doi:10.1038/jes.2009.41.
   PubMed Web of Science ®Google Scholar
• Strickland P, Kang D. Urinary 1-hydroxypyrene and other PAH metabolites as biomarkers of exposure to environmental PAH in air particulate matter. Toxicol Lett. 1999;108(2-3):191–199. doi:10.1016/S0378-4274(99)00089-2.
   PubMed Web of Science ®Google Scholar